"Wir führen ausschließlich klinische Studien durch. Patienten können sich auf unserer Homepage über unsere aktuellen Studien informieren und ggf. einen Termin vereinbaren."

During the past decade, Klifos - Klinische Forschung Osnabruck conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klifos - Klinische Forschung Osnabruck" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "UNION therapeutics" with 2 trials sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klifos - Klinische Forschung Osnabruck" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Klifos - Klinische Forschung Osnabruck" are "Atopic Dermatitis" (3 trials), "Psoriasis" (2 trials), "Skin Diseases" (2 trials), "Chronic Hand Eczema (CHE)" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Klifos - Klinische Forschung Osnabruck" in a lesser frequency.

Most popular intervention types in "Klifos - Klinische Forschung Osnabruck" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Orismilast modified release tablets" (2 trials), "Ruxolitinib cream" (2 trials), "Vehicle" (2 trials) and "BMS-986166" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klifos - Klinische Forschung Osnabruck" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Klifos - Klinische Forschung Osnabruck". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Klifos - Klinische Forschung Osnabruck, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klifos - Klinische Forschung Osnabruck, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".